These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31745972)

  • 21. Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection.
    Kim HJ; Kim N; Kim HY; Lee HS; Yoon H; Shin CM; Park YS; Park DJ; Kim HH; Lee KH; Kim YH; Kim HM; Lee DH
    Gastric Cancer; 2015 Oct; 18(4):762-73. PubMed ID: 25240409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
    Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
    Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men.
    Epplein M; Zheng W; Li H; Peek RM; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Xiang YB; Shu XO
    Nutr Cancer; 2014; 66(4):550-7. PubMed ID: 24666234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries.
    Shiota S; Matsunari O; Watada M; Yamaoka Y
    Future Microbiol; 2010 Dec; 5(12):1885-93. PubMed ID: 21155667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.
    González CA; Megraud F; Buissonniere A; Lujan Barroso L; Agudo A; Duell EJ; Boutron-Ruault MC; Clavel-Chapelon F; Palli D; Krogh V; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Sanchez-Cantalejo E; Navarro C; Barricarte A; Dorronsoro M; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Bas Bueno-de-Mesquita H; Jeurnink SM; Numans ME; Peeters PHM; Lagiou P; Valanou E; Trichopoulou A; Kaaks R; Lukanova-McGregor A; Bergman MM; Boeing H; Manjer J; Lindkvist B; Stenling R; Hallmans G; Mortensen LM; Overvad K; Olsen A; Tjonneland A; Bakken K; Dumeaux V; Lund E; Jenab M; Romieu I; Michaud D; Mouw T; Carneiro F; Fenge C; Riboli E
    Ann Oncol; 2012 May; 23(5):1320-1324. PubMed ID: 21917738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LTA 252GG and GA genotypes are associated with diffuse-type noncardia gastric cancer risk in the Japanese population.
    Suzuki G; Cullings H; Fujiwara S; Matsuura S; Kishi T; Ohishi W; Akahoshi M; Hayashi T; Tahara E
    Helicobacter; 2009 Dec; 14(6):571-9. PubMed ID: 19889075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: A meta-analysis.
    El Hafa F; Wang T; Ndifor VM; Jin G
    Helicobacter; 2022 Jun; 27(3):e12881. PubMed ID: 35212073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Helicobacter pylori infection and gastric cardia cancer: a nested case-control study].
    Ren JS; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):428-31. PubMed ID: 19024516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
    Parsonnet J; Friedman GD; Orentreich N; Vogelman H
    Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori infection and gastric cancer: evidence from a retrospective cohort study and nested case-control study in China.
    Wang RT; Wang T; Chen K; Wang JY; Zhang JP; Lin SR; Zhu YM; Zhang WM; Cao YX; Zhu CW; Yu H; Cong YJ; Zheng S; Wu BQ
    World J Gastroenterol; 2002 Dec; 8(6):1103-7. PubMed ID: 12439934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort.
    Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between dietary factors and Helicobacter pylori infection in noncardia gastric cancer: a population-based case-control study in China.
    Wang XQ; Yan H; Terry PD; Wang JS; Cheng L; Wu WA; Hu SK
    J Am Coll Nutr; 2012 Oct; 31(5):375-84. PubMed ID: 23529995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of IgG antibody titer against Helicobacter pylori.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans.
    Longo-Mbenza B; Nsenga JN; Mokondjimobe E; Gombet T; Assori IN; Ibara JR; Ellenga-Mbolla B; Vangu DN; Fuele SM
    Vasc Health Risk Manag; 2012; 6():455-61. PubMed ID: 22923995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.
    Epplein M; Butt J; Zhang Y; Hendrix LH; Abnet CC; Murphy G; Zheng W; Shu XO; Tsugane S; Qiao YL; Taylor PR; Shimazu T; Yoo KY; Park SK; Kim J; Jee SH; Waterboer T; Pawlita M; You WC; Pan KF
    Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1472-1479. PubMed ID: 30158280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of gastric cancer among smokers infected with Helicobacter pylori.
    Brenner H; Arndt V; Bode G; Stegmaier C; Ziegler H; Stümer T
    Int J Cancer; 2002 Mar; 98(3):446-9. PubMed ID: 11920598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
    Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.